Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.3553
-0.0011 (-0.31%)
At close: Nov 18, 2026, 4:00 PM EST
0.3619
+0.0066 (1.86%)
After-hours: Nov 18, 2026, 7:30 PM EST
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $30.65 million as of November 18, 2026. It is the 33,338th most valuable company in the world and the 4,851st biggest in the United States. Its market cap has decreased by 4.52% in one year.
Market Cap
30.65M
Enterprise Value
-4.84M
1-Year Change
-4.52%
Global Rank
Country Rank
#4,851 United States
Category
ChartMarket Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $30.65M, a decrease of -80.71%. That is a compound annual growth rate of -16.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 30.60M | 0.33% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 32.11M |
| BriaCell Therapeutics | 30.53M |
| INmune Bio | 30.47M |
| Adicet Bio | 29.94M |
| NanoViricides | 29.86M |
| ProMIS Neurosciences | 28.61M |
| LeonaBio | 28.45M |
| Edesa Biotech | 27.29M |